Ignite Creation Date:
2024-05-06 @ 8:05 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06255197
Status:
RECRUITING
Last Update Posted:
2024-02-16
First Post:
2024-02-04
Brief Title:
Characteristics Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Sponsor:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Organization:
Cancer Institute and Hospital Chinese Academy of Medical Sciences
Study Overview
Official Title:
Characteristics Treatment Patterns and Outcomes for Patients With Surgically Resected Lung Cancers
Status:
RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study is a multi-center observational real-world study for patients with resected lung cancers in China With the help of a properly designed data processing algorithm and extensively performed data quality assurance this study aims to harness the potential of real-world big data to 1 describe characteristics and treatment patterns and their evolving trends 2 discover features associated with overall survival and 3 address recently-emerging clinical questions
Detailed Description:
Lung cancer is the leading cause of cancer-related deaths in China The recent decade witnessed rapid evolving of demographics pathological features and prognoses of patients with surgically resected lung cancers The introduction of minimally invasive surgery MIS concept and techniques targeted therapy and immunotherapy changed treatment landscape for patients with surgically resected lung cancers With more early-stage lung cancers discovered due to the application of CT screening questions focusing on extent of lung resection lymph node dissection application of targeted or immune-therapy to early-stage lung cancers are emerging This study aims to create a cohort of patients with surgically resected lung cancers and an analytic framework to address the aforementioned clinical questions
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None